
Please try another search
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products. The company offers anti-HIV products; ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. The company was founded in 2009 and is headquartered in Yangzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Jun Wang | 49 | 2019 | VP & Director |
Heliang Fu | 63 | 2014 | Chairman |
Heng Yu | 45 | 2020 | Chairman of the Supervisory Board |
Ke Yu | 46 | 2020 | VP & Director |
Jie Zhang | 54 | 2023 | CEO, President & Director |
Zijian Guo | 62 | 2023 | Independent Director |
Haiwang Ji | 47 | 2023 | Employee Representative Supervisor |
Guang Ji Wang | 70 | 2019 | Independent Director |
Xiao Yan Qi | 61 | 2022 | Independent Director |
Feng Ying He | 42 | 2020 | Supervisor |
Guang Rong Wang | 47 | 2019 | VP & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review